קלרל סיסטם - סלניום ויטאדרמין Iisrael - heebrea - Ministry of Health

קלרל סיסטם - סלניום ויטאדרמין

ברזילי ייבוא ושיווק למספרות בעמ - חיזוק סיב השערה

פרגמין 2500 יבל0.2 מל Iisrael - heebrea - Ministry of Health

פרגמין 2500 יבל0.2 מל

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - תמיסה להזרקה - dalteparin sodium 2500 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

פרגמין 2500 יב''למ''ל Iisrael - heebrea - Ministry of Health

פרגמין 2500 יב''למ''ל

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - תמיסה להזרקה - dalteparin sodium 2500 iu/ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections. cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.

נימנריקס Iisrael - heebrea - Ministry of Health

נימנריקס

pfizer pharmaceuticals israel ltd - neisseria meningitidis group a polysaccharide; neisseria meningitidis group c polysaccharide; neisseria meningitidis group w - 135 polysaccharide; neisseria meningitidis group y polysaccharide - אבקה וממס להכנת תמיסה להזרקה - neisseria meningitidis group y polysaccharide 5 mcg; neisseria meningitidis group w - 135 polysaccharide 5 mcg; neisseria meningitidis group c polysaccharide 5 mcg; neisseria meningitidis group a polysaccharide 5 mcg - other meningococcal monovalent purified polysaccharides antigen - other meningococcal monovalent purified polysaccharides antigen - nimenrix is indicated for active immunisation of individuals from the age of 12 months and above against invasive meningococcal diseases caused by neisseria meningitidis group a, c, w-135 and y.

איקסיפי Iisrael - heebrea - Ministry of Health

איקסיפי

pfizer pfe pharmaceuticals israel ltd - infliximab - אבקה להכנת תמיסה מרוכזת לעירוי - infliximab 100 mg - infliximab

היקיוביה Iisrael - heebrea - Ministry of Health

היקיוביה

takeda israel ltd - human normal immunoglobulin - תמיסה לאינפוזיה - human normal immunoglobulin 100 mg / 1 ml - immunoglobulins, normal human, for intravascular adm.

טיקוואק 0.5 מל Iisrael - heebrea - Ministry of Health

טיקוואק 0.5 מל

pfizer pharmaceuticals israel ltd - encephalitis, tick borne, inactivated, whole virus - תרחיף להזרקה - encephalitis, tick borne, inactivated, whole virus 2.4 mcg / 0.5 ml - encephalitis, tick borne, inactivated, whole virus

טיקוואק ג'וניור 0.25 מל Iisrael - heebrea - Ministry of Health

טיקוואק ג'וניור 0.25 מל

pfizer pharmaceuticals israel ltd - encephalitis, tick borne, inactivated, whole virus - תרחיף להזרקה - encephalitis, tick borne, inactivated, whole virus 1.2 mcg / 0.25 ml - encephalitis, tick borne, inactivated, whole virus

למטרדה Iisrael - heebrea - Ministry of Health

למטרדה

sanofi israel ltd - alemtuzumab - תרכיז להכנת תמיסה לאינפוזיה - alemtuzumab 12 mg / 1.2 ml - alemtuzumab

פרגמין 10000 יב''למ''ל Iisrael - heebrea - Ministry of Health

פרגמין 10000 יב''למ''ל

pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - תמיסה להזרקה - dalteparin sodium 10000 iu/ml - dalteparin